Grants awarded from the money raised by the NWA Metsquerade fundraisers since 2016:
Presented by NWA Metsquerade in Memory of Lisa Quinn and In Honor of Kelli Davis-Jill Bargonetti, PhD, City University of New York (CUNY) at Hunter College-"Targeting Metastatic Breast Cancer Through the Mutant p53-PARP Axis" 2021
Northwest Arkansas Metsquerade Presented In Memory of Erin Leland - Traci Lyons, PhD, University of Colorado Anschutz Medical Campus - "Targeting therapeutic vulnerabilities of endocrine therapy resistant ER+ metastatic breast cancer" 2020
Northwest Arkansas Metsquerade Presented In Memory of Angie Powell - Colt Egelston, PhD, City of Hope - "Bispecific monoclonal antibodies for treatment of advanced breast cancer" 2019
Northwest Arkansas Metsquerade Presented In Memory of Wendy Taylor - Stuart Martin, PhD, University of Maryland School of Medicine - "Reducing the risk of chemotherapy-induced scattering of metastatic triple-negative breast tumors" 2019
Northwest Arkansas Metsquerade Presented In Memory of Valerie Wright - Danny Welch, PhD, University of Kansas Medical Center University of Kansas Cancer Center - "New inhibitors of breast cancer metastasis" 2019
METAribbon Challengers Present - Madeline Oudin, BSc, MSc, PhD, Tufts University - "Investigating how obesity-driven changes in the tumor microenvironment promote metastatic outgrowth and chemoresistance in metastatic TNBC" 2019
The METAribbon Challengers present Julio Aguirre-Ghiso, PhD, Professor, Medicine, Hematology and Medical Oncology, Otolaryngology, Oncological Sciences, Icahn School of Medicine "Targeting Intrinsic And Immune Mechanisms In Persistent Dormant Cancer Cells In Stage IV Breast Cancer" 2018
The Davis-Quinn Northwest Arkansas Metsquerade presents Brad St Croix, PhD, Senior Associate Scientist, National Cancer Institute "Improving Immunotherapies for Advanced Metastatic Breast Cancer" 2018
The Quinn-Davis Northwest Arkansas Metsquerade presents Dr. Cheryl Jorcyk, Director of Clinical/Translational Research, Boise State University: "High impact therapeutic for the elimination of breast cancer metastasis to bone" 2017
The Parker-Quinn METSquerade Award 2016
Click here to visit all of the grants awarded by Metavivor Research & Support.